SEC Form 4 · accession 0001144204-16-117030
China Biologic Products, Inc. · CBPO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Hui Li
Director
Period of report
Aug 4, 2016
Accepted (ET)
Aug 8, 2016 · 8:30 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001369868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted StockF1 | Aug 4, 2016 | A | 5,000 | $0.00 | A | 25,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the grant of restricted stock to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a restricted stock grant agreement dated August 4, 2016 (the "Restricted Stock Agreement"). The restricted stock will vest and the Issuer's right to reacquire the restricted stock will lapse over a 24-month period in two equal portions, with an initial vesting date on August 5, 2017, provided that the Reporting Person has been continuously a Service Provider (as defined in the Restricted Stock Agreement) from August 4, 2016 until the date such vesting occurs.